Home›Search›Targeted Oncology

Targeted Oncology

Springer Paris · France · Est. 1874

ISSN1776-2596eISSN1776-260X

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

Total60

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.645

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

1.12

Total Works

1,203

Total Citations

26,289

2yr Mean Citedness

3.76

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal focuses on the clinical application and real-world outcomes of targeted therapies and immunotherapies across various cancers, including renal cell carcinoma, non-small cell lung cancer, melanoma, gastric cancer, and multiple myeloma. It examines the efficacy, safety, and predictive biomarkers of treatments such as pembrolizumab, nivolumab, tyrosine kinase inhibitors, antibody-drug conjugates, and bispecific antibodies. The scope also includes the investigation of novel therapeutic targets, molecular profiling for personalized medicine, and challenges in treatment selection and administration.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 25% in field

General Information

Country / RegionFrance

Primary LanguageEnglish

1st Year Published1874

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications1,203

Publisher OrgAdis, Springer Healthcare

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer Paris

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1776-2596 / 1776-260X

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ1

Pharmacology (medical)Q1

Cancer ResearchQ2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Pharmacology (medical)Cancer ResearchOncology

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersLung Cancer Research StudiesHER2/EGFR in Cancer ResearchRenal cell carcinoma treatmentCancer Genomics and DiagnosticsLung Cancer Diagnosis and TreatmentGastric Cancer Management and OutcomesAdvanced Breast Cancer Therapies